Clinical Trials Logo
  1. Home
  2. Mucormycosis
  3. NCT05406037

Biomarkers for Invasive Mucormycosis — BIM  

Mucormycosis Clinical Trial

Official title:
Diagnostic Marker of Mucormycosis : Development and Evaluation of a Diagnostic Assay on a Cohort of Sera

Clinical Trial Summary

Mucormycosis (MM) is one of the main invasive fungal infection (IFI), and is determined by filamentous fungi belonging to the order of Mucorales, with a mortality rate ranging from 20 to 60% according to localization. Prompt initiation of adequate antifungal therapy is critical for treating mucormycosis. Early diagnostic is therefore essential. The presence in the Mucorales' cell wall of uncommon monosaccharides open interesting perspectives for the development of specific diagnostic biomarkers. This study evaluate a diagnostic test for mucormycosis in a cohort of patients with MM and in control groups (high-risk patients without MM and patients with another IFI).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05406037
Study type Observational
Source University Hospital, Lille
Contact Marjorie CORNU, MD
Phone 0320445962
Email marjorie.cornu@chru-lille.fr
Status Not yet recruiting
Phase
Start date July 2022
Completion date August 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03387696 - Mucormycosis in ICU
Recruiting NCT04744454 - Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Completed NCT00419770 - The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study Phase 2
Recruiting NCT05925660 - Mucorales PCR Screening in At-risk Hematology Patients N/A
Completed NCT04935463 - Mucormycosis in COVID-19
Completed NCT04550936 - Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis
Completed NCT05074043 - COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
Not yet recruiting NCT06440915 - Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children N/A
Completed NCT02845934 - Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis N/A
Completed NCT05348434 - Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
Completed NCT05212961 - COVID-19 and Rhino-orbital Mucormycosis
Recruiting NCT05097664 - Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran